Assessment of the CYP450 inhibitory potential of LSD, 5-MeO-DMT and mescaline: an in vitro study
Science Letters · 17.04.2023
DOI: 10.48797/sl.2023.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Letters, erschienen am 17.04.2023. Verfasst von Silva-Carvalho und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
LSD, 5-MeO-DMT and mescaline are classic hallucinogens known for their recreational use, whose consumption increased in the last decades. Despite some available data on the toxicokinetics of these drugs, little is known about their CYP450 metabolism [1,2,3]. Nevertheless, this information is of crucial relevance to predict drug-drug interactions and understand toxicological phenomena, in particular interindividual variability.
Objective
This study evaluated the potential inhibition of LSD, 5-MeO-DMT and mescaline over CYP450 isoenzymes (CYP3A4, CYP2D6, CYP2B6 and CYP2A6).
Methods
The Vivid® CYP450 screening kits were used following the manufacturer’s instructions. Concentration ranges tested for each drug were 6.1x10-5–1.0 mM, 1.95x10-4–4.0 mM and 6.1x10-5–1.0 mM for CYP3A4; 9.54x10-8–1.0 mM, 9.54x10-7–4.0 mM and 6.1x10-5–4.0 m for CYP2D6; 2.56x10-5–2.0 mM, 2.44x10-4–6.0 mM and 6.1x10-5–4.0 mM for CYP2B6; and 1.91x10-6–1.0 mM, 2.86x10-6–4.0 mM and 2.29x10-5–1.0 mM for CYP2A6, for LSD, 5-MeO-DMT and mescaline, respectively. Solvent and positive controls of inhibition, i.e., ketononazole (CYP3A4), quinidine (CYP2D6), miconazole (CYP2B6) and tranylcypromine (CYP2A6) were used. Fluorescence was measured for 60 minutes at excitation and emission wavelengths of 415/20 and 460/20 nm, respectively. The half-maximal inhibitory concentration (IC50) was calculated using GraphPad Prism 9.3.0. Five independent experiments were performed for CYP3A4, four for CYP2D6 and two for CYP2B6 and 2A6.
Results
IC50 values of 80.92 mM, 203.27 mM, 97.59 mM for CYP3A4; 0.61 mM, 3.47 mM, 558.53 mM for CYP2D6; 604.68 mM, 653.55 mM, 323.98 mM for CYP2B6; and 54.44 mM, 124.82 mM, 96.35 mM for CYP2A6, were obtained for LSD, 5-MeO-DMT and mescaline, respectively.
Conclusions
LSD and 5-MeO-DMT have a strong potential to inhibit CYP2D6, which is highly polymorphic and therefore implicated in great toxicological interindividual variability. CYP3A4 which is involved in the metabolism of many drugs and food is also greatly inhibited by LSD and mescaline.
Schlagwörter
Zitieren
APA
Silva-Carvalho, M., Brito-Da-Costa, M., A., Dinis‐Oliveira, R. J., Madureira-Carvalho, Á., & Silva, D. D. D. (2023). Assessment of the CYP450 inhibitory potential of LSD, 5-MeO-DMT and mescaline: an in vitro study. Science Letters. https://doi.org/10.48797/sl.2023.103
Vancouver
Silva-Carvalho, M., Brito-Da-Costa, M. A, Dinis‐Oliveira RJ, Madureira-Carvalho, et al. Assessment of the CYP450 inhibitory potential of LSD, 5-MeO-DMT and mescaline: an in vitro study. Science Letters. 2023. doi:10.48797/sl.2023.103
BibTeX
@article{SilvaCarvalho2023,
author = {Silva-Carvalho and M. and Brito-Da-Costa and M., A. and Dinis‐Oliveira, Ricardo Jorge and Madureira-Carvalho and Á. and Silva, Diana Dias da},
title = {Assessment of the CYP450 inhibitory potential of LSD, 5-MeO-DMT and mescaline: an in vitro study},
journal = {Science Letters},
year = {2023},
doi = {10.48797/sl.2023.103}
}
EUVIMED